Cargando…
SARS-CoV-2 neutralizing antibody development strategies
In December 2019 a novel coronavirus was detected in Wuhan City of Hubei Province-China. Owing to a high rate of transmission from human to human, the new virus called SARS-CoV-2 differed from others by its unexpectedly rapid spread. The World Health Organization (WHO) described the most recent coro...
Autores principales: | BALCIOĞLU, Bertan Koray, DENİZCİ ÖNCÜ, Melis, ÖZTÜRK, Hasan Ümit, YÜCEL, Fatıma, KAYA, Filiz, SERHATLI, Müge, ÜLBEĞİ POLAT, Hivda, TEKİN, Şaban, ÖZDEMİR BAHADIR, Aylin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific and Technological Research Council of Turkey
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314503/ https://www.ncbi.nlm.nih.gov/pubmed/32595357 http://dx.doi.org/10.3906/biy-2005-91 |
Ejemplares similares
-
Identifying specific matrix metalloproteinase-2-inhibiting peptides through phage display-based subtractive screening
por: ÖZDEMİR BAHADIR, Aylin, et al.
Publicado: (2021) -
The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
por: Durdagi, Serdar, et al.
Publicado: (2022) -
Therapeutic Effect of C-Vx Substance in K18-hACE2 Transgenic Mice Infected with SARS-CoV-2
por: Ulbegi Polat, Hivda, et al.
Publicado: (2023) -
Nanobubble Ozone Stored in Hyaluronic Acid Decorated Liposomes: Antibacterial, Anti-SARS-CoV-2 Effect and Biocompatibility Tests
por: Sabancı, Ahmet Umit, et al.
Publicado: (2022) -
Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid
por: Unal, Gokhan, et al.
Publicado: (2020)